EXICURE, INC. Loan Processing Fee
EXICURE, INC. (XCUR) had Loan Processing Fee of $125.00 thousand as of 2020-09-25, per its 10-Q filed 2021-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LoanProcessingFee · last filed 2021-11-19
- 2020-09-25: Loan Processing Fee $125.00K.
| Period end | Loan Processing Fee |
|---|---|
| 2020-09-25 | $125.00K 10-Q · filed 2021-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |